Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was …
HSJ Choi, WP Brouwer, WMR Zanjir, RA de Man… - …, 2020 - Wiley Online Library
Background and Aims Chronic hepatitis B (CHB) and nonalcoholic fatty liver disease are increasingly observed together in clinical practice, and development of nonalcoholic …
Methods We searched 4 databases from inception to December 2021 and pooled study- level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …
SC Huang, CJ Liu - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide …
J Li, HI Yang, ML Yeh, MH Le, AK Le… - The Journal of …, 2021 - academic.oup.com
Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …
QI Zheng, B Zou, Y Wu, Y Yeo, H Wu… - Alimentary …, 2021 - Wiley Online Library
Background As the prevalence of hepatitis steatosis (HS) increases, the prevalence of HS among those with chronic hepatitis B (CHB) may also be increasing but data on the effect of …
M Yang, L Wei - Liver International, 2022 - Wiley Online Library
Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular …
P Golabi, L Rhea, L Henry, ZM Younossi - Hepatology international, 2019 - Springer
Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder worldwide, affecting 25.2% of the general population. In fact, NAFLD is among the most …